Product information and disease descriptionPlace of product in therapyApproaches to treatmentCurrent treatment options and standard of care
Sleep management
6 evidence topics · 6 sources
Consensus guideline: melatonin, trazodone, clonidine, bed safety, iron, and sleep study
“Circadian rhythm is often disrupted; consider melatonin to initiate sleep and trazodone or clonidine to maintain asleep. Patient may be getting out of bed, which could be unsafe; consider a tent-style bed or similar engineering controls to keep child in bed and safe. Consider ferritin, serum iron, total iron binding capacity and transferrin levels if there is disrupted sleep or concerns for restless leg syndrome and need for iron replacement. Consider overnight sleep study for snoring or pauses in breathing.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
Sleep hygiene and medication use: International Rett Syndrome Phenotype Database
“Sleep disturbances are debilitating for individuals with Rett syndrome (RTT) and their families yet the evidence base for management is poor.” (opens the original PubMed page at this quote in a new tab)View highlighted excerpt for this quote
“Data were provided by 364/461 (79%) families with a child with RTT and registered with the International RTT Phenotype Database.” (opens the original PubMed page at this quote in a new tab)View highlighted excerpt for this quote
“Better use of sleep hygiene practices was associated with lower odds of moderate/major impact on the family (odds ratio 0.60, 95% confidence intervals [CIs] 0.37, 0.98) and lower DIMS scores (geometric mean ratio 0.86, 95%CI 0.80, 0.92) compared with poorer use after adjusting for covariates.” (opens the original PubMed page at this quote in a new tab)View highlighted excerpt for this quote
“Attention to sleep hygiene remains an important management strategy for sleep problems in RTT. Further prospective research is required to investigate efficacy of pharmaceutical treatments.” (opens the original PubMed page at this quote in a new tab)View highlighted excerpt for this quote
Melatonin: double-blind, placebo-controlled crossover trial
“Subsequently, patients underwent a 4-week melatonin treatment period in a double-blind, placebo-controlled, crossover protocol that employed a 1-week washout between treatment trials. Melatonin doses ranged from 2.5 to 7.5 mg, based upon individual body weight.” (opens the original PubMed page at this quote in a new tab)View highlighted excerpt for this quote
“Melatonin significantly decreased sleep-onset latency to (mean +/- SE) 19.1+/-5.3 minutes (P<0.05) during the first 3 weeks of treatment.” (opens the original PubMed page at this quote in a new tab)View highlighted excerpt for this quote
“Finally, a 4-week administration of melatonin appears to be a safe treatment as no adverse side effects were detected, yet long-term effects of chronic melatonin use in pediatric patients are unknown at this time.” (opens the original PubMed page at this quote in a new tab)View highlighted excerpt for this quote
Multidisciplinary clinic cohort: sleep medications prescribed
“Melatonin was the most common medication prescribed in our cohort and is most helpful for sleep initiation [28]. Other medications commonly prescribed for management of sleep disturbance included clonidine, chloral hydrate, Phenergan and risperidone [28].” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
Obstructive sleep apnea on polysomnography and screening
“Six of thirteen participants had obstructive sleep apnea, which was worse during rapid eye movement (REM) sleep with associated hypoxemia and disruptions in sleep architecture.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“This suggests that providers should routinely screen for sleep problems and implement interventions that can positively impact the quality of life of individuals with Rett syndrome and their families.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
Narrative review: sleep hygiene as first-line therapy
“Evidence on management of sleep disorders is lacking, as no algorithms are available, the choice of therapy depends on each case (15, 95).” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“To date, sleep hygiene remains the first-line therapy. Although melatonin has been shown to be effective in improving total sleep time and sleep onset latency, the literature on drug efficacy and safety is poor and drug trials need to be designed.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote